Page last updated: 2024-08-26

vinpocetine and Lung Neoplasms

vinpocetine has been researched along with Lung Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Hong, Y; Huang, Y; Huang, Z; Zhu, K; Zhuang, Q; Zhuang, W	1

Other Studies

1 other study(ies) available for vinpocetine and Lung Neoplasms

Article	Year
Vinpocetine enhances cisplatin sensitivity of non-small cell lung cancer cells by reducing the nuclear factor erythroid 2-related factor 2 signaling. Journal of investigative medicine : the official publication of the American Federation for Clinical Research, 2022, Volume: 70, Issue:6 Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Cisplatin; Drug Resistance, Neoplasm; Humans; Lung Neoplasms; MicroRNAs; NF-E2-Related Factor 2; Vinca Alkaloids	2022

Article

Year

Vinpocetine enhances cisplatin sensitivity of non-small cell lung cancer cells by reducing the nuclear factor erythroid 2-related factor 2 signaling.

Journal of investigative medicine : the official publication of the American Federation for Clinical Research, 2022, Volume: 70, Issue:6

Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Cisplatin; Drug Resistance, Neoplasm; Humans; Lung Neoplasms; MicroRNAs; NF-E2-Related Factor 2; Vinca Alkaloids

2022